Developing potent BTKC481S PROTACs for ibrutinib-resistant malignant lymphoma

Yonghui Sun(Tsinghua University), Yu Rao(Soochow University), Xin Luo(Tokyo University of Agriculture), Zimo Yang(University of Electronic Science and Technology of China), Lixia Chen(Shanxi University of Traditional Chinese Medicine), Hua Li(Fujian University of Traditional Chinese Medicine), Wenxing Lv(Tsinghua University)
Chinese Chemical Letters
October 20, 2022
10.1016/j.cclet.2022.107924
Cited by 6

Related Papers

PROTACs: great opportunities for academia and industry
|Signal Transduction and Targeted Therapy|2019|627
Crystal structure of a bacterial homologue of glucose transporters GLUT1–4
|Nature|2012|488
An overview of calibration technology of industrial robots
|IEEE/CAA Journal of Automatica Sinica|2021|370
PROTAC Technology: Opportunities and Challenges
|ACS Medicinal Chemistry Letters|2020|353
Prospectively Isolated Tetraspanin+ Neoblasts Are Adult Pluripotent Stem Cells Underlying Planaria Regeneration
|Cell|2018|304